NEW PRODUCT DEVELOPMENT

NEW PRODUCT DEVELOPMENT

Over 25 years experience with biotechnology new product development impacting health globally.
Over 25 years experience with biotechnology new product development impacting health globally.

HEALTH TECHNOLOGY
  • Developed groundbreaking FDA cleared products including current molecular tests ensuring safety of U.S. blood supply (HIV, HCV, HBV, West Nile Virus) (Gen-Probe)
  • Launched first combined Chlamydia and Gonorrhea molecular tests, eliminated need for male genital swabbing with first molecular testing for urine (Gen-Probe)
  • Developed diagnostics with molecular, immunoassay, and genetic engineering platforms (Gen-Probe, Nanogen - Vectrant, Exonhit, Intrexon)
  • Marketed diagnostic, cell and gene therapy, and vectored vaccine technologies using molecular, genetic, and genome engineering platforms (Intrexon)

GLOBAL PUBLIC HEALTH & NATIONAL SECURITY
  • Developed, deployed, and marketed infectious disease testing and vector control interventions for mosquito-borne diseases (Gen-Probe, St. Gabriel’s Hospital - Malawi, Intrexon, Oxitec)

FOOD TECHNOLOGY

  • Marketed and advanced development of food products and agricultural innovations using genetically engineered, gene-edited, and cloned organisms serving as first-in-class food products for FDA and USDA regulators (fish, fruit, livestock) (Intrexon - see list of subsidiaries and affiliates)

ENVIRONMENTAL INTERVENTIONS & CONSERVATION

  • Developed and marketed multiple environmental threat detection systems for biosecurity (Gen-Probe, Nanogen - Vectrant)
  • Pioneered development of gene-edited environmental clean-up systems for emerging contaminants of concern (COCs) (Intrexon)
HEALTH TECHNOLOGY
  • Developed groundbreaking FDA cleared products including current molecular tests ensuring safety of U.S. blood supply (HIV, HCV, HBV, West Nile Virus) (Gen-Probe)
  • Launched first combined Chlamydia and Gonorrhea molecular tests, eliminated need for male genital swabbing with first molecular testing for urine (Gen-Probe)
  • Developed diagnostics with molecular, immunoassay, and genetic engineering platforms (Gen-Probe, Nanogen - Vectrant, Exonhit, Intrexon)
  • Marketed diagnostic, cell and gene therapy, and vectored vaccine technologies using molecular, genetic, and genome engineering platforms (Intrexon)

GLOBAL PUBLIC HEALTH & NATIONAL SECURITY
  • Developed, deployed, and marketed infectious disease testing and vector control interventions for mosquito-borne diseases (Gen-Probe, St. Gabriel’s Hospital - Malawi, Intrexon, Oxitec)

FOOD TECHNOLOGY

  • Marketed and advanced development of food products and agricultural innovations using genetically engineered, gene-edited, and cloned organisms serving as first-in-class food products for FDA and USDA regulators (fish, fruit, livestock) (Intrexon - see list of subsidiaries and affiliates)

ENVIRONMENTAL INTERVENTIONS & CONSERVATION

  • Developed and marketed multiple environmental threat detection systems for biosecurity (Gen-Probe, Nanogen - Vectrant)
  • Pioneered development of gene-edited environmental clean-up systems for emerging contaminants of concern (COCs) (Intrexon)